CELLPOINT stock news
This page provides real-time market news, earnings updates, and company announcements related to Cell Point (India) Limited (CELLPOINT).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-21 22:52 IST

ProKidney’s Greensboro Facility Could Shield It From Looming Tariff Risks—But Time Is Short
101 finance2026-03-20 06:18:49

ProKidney Makes Major Wager on U.S. Tariff Relief—Does Consistent Policy Support a $485M Risk?
101 finance2026-03-20 06:19:02

Tesla’s $20B Capex Bet on Robotaxi and Optimus Risks Overlooking the Auto Slump and Execution Gaps
101 finance2026-03-20 10:42:45

Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Finviz2026-03-20 12:33:48

Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:30:13

Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:36:47

Caris Life Sciences’ GPSai Drives the S-Curve of AI Infrastructure in Precision Oncology—Market Overlooks the Momentum
101 finance2026-03-20 13:03:53

Vertex Shares Drop 4.8% Over the Past Month: Is This a Chance to Buy or a Warning Sign?
101 finance2026-03-20 13:03:54

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-20 14:06:49

VanEck Associates Has Increased Its Investment in AST SpaceMobile by Over Twofold. Could This Be an Opportune Moment to Invest in the Satellite Producer?
101 finance2026-03-20 14:12:33

GE Aerospace vs. Textron: Which Aerospace & Defense Stock Is the Better Investment Choice?
101 finance2026-03-20 16:27:43
1 Stock That Hasn't Delivered Profits for Years and 2 Encountering Challenges
101 finance2026-03-20 16:30:50

Sanofi's $600M DR-0201 Bet: Market May Have Already Priced In the Pipeline Reset
101 finance2026-03-20 16:52:04
Cellectis’ Pivotal Study Timelines and Milestone Eligibility Clash in 2025 Q4 Earnings Call
101 finance2026-03-20 17:16:00

Tivic Health’s sharp decline approaching its 52-week low indicates the market may have already factored in a BLA failure—Could this be a binary scenario for a potential regulatory turnaround?
101 finance2026-03-20 19:57:43

Novartis Inks $3 Billion Cancer Agreement for Breast Tumor Therapy
101 finance2026-03-20 20:01:01

Biofrontera’s New Royalty Agreement Drives Gross Margins Above 82%, Opening Up New Profit Opportunities
101 finance2026-03-20 22:49:16
AEP Shares Drop 2.38% Despite Record $1.09B Volume (207th in U.S.) as Strategic SoftBank Alliance Sparks Market Debate
101 finance2026-03-20 23:33:34
Why Shares of Fluence Energy (FLNC) Are Declining Today
101 finance2026-03-21 01:57:40

Cellectis Reports Net Loss Surging by 544% Even as Trial Outcomes Show Promise
101 finance2026-03-21 07:12:46

AST SpaceMobile's BlueBird 7 Launch and $30M Gov Contract: Can It Justify 106x Sales Before Burnout?
101 finance2026-03-21 07:27:43

AST SpaceMobile’s Patent-Protected Direct-to-Cell Play Faces Looming SpaceX IPO Threat
101 finance2026-03-21 07:30:51

Dizal’s ZEGFROVY Nears First-Line Standard Status as Phase 3 Win Unlocks New Market
101 finance2026-03-21 12:03:40

Tesla’s Terafab Gambit: Can It Solve 2nm Chip Hurdles Before Burning Through $40 Billion?
101 finance2026-03-21 13:30:41

Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:30:13

Is Now a Good Time to Invest in CRISPR Therapeutics Stock?
101 finance2026-03-20 12:36:47

Caris Life Sciences’ GPSai Drives the S-Curve of AI Infrastructure in Precision Oncology—Market Overlooks the Momentum
101 finance2026-03-20 13:03:53

Vertex Shares Drop 4.8% Over the Past Month: Is This a Chance to Buy or a Warning Sign?
101 finance2026-03-20 13:03:54

Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-20 14:06:49

VanEck Associates Has Increased Its Investment in AST SpaceMobile by Over Twofold. Could This Be an Opportune Moment to Invest in the Satellite Producer?
101 finance2026-03-20 14:12:33

GE Aerospace vs. Textron: Which Aerospace & Defense Stock Is the Better Investment Choice?
101 finance2026-03-20 16:27:43
1 Stock That Hasn't Delivered Profits for Years and 2 Encountering Challenges
101 finance2026-03-20 16:30:50

Sanofi's $600M DR-0201 Bet: Market May Have Already Priced In the Pipeline Reset
101 finance2026-03-20 16:52:04
Cellectis’ Pivotal Study Timelines and Milestone Eligibility Clash in 2025 Q4 Earnings Call
101 finance2026-03-20 17:16:00

Tivic Health’s sharp decline approaching its 52-week low indicates the market may have already factored in a BLA failure—Could this be a binary scenario for a potential regulatory turnaround?
101 finance2026-03-20 19:57:43

Novartis Inks $3 Billion Cancer Agreement for Breast Tumor Therapy
101 finance2026-03-20 20:01:01

Biofrontera’s New Royalty Agreement Drives Gross Margins Above 82%, Opening Up New Profit Opportunities
101 finance2026-03-20 22:49:16
AEP Shares Drop 2.38% Despite Record $1.09B Volume (207th in U.S.) as Strategic SoftBank Alliance Sparks Market Debate
101 finance2026-03-20 23:33:34
Why Shares of Fluence Energy (FLNC) Are Declining Today
101 finance2026-03-21 01:57:40

Cellectis Reports Net Loss Surging by 544% Even as Trial Outcomes Show Promise
101 finance2026-03-21 07:12:46

AST SpaceMobile's BlueBird 7 Launch and $30M Gov Contract: Can It Justify 106x Sales Before Burnout?
101 finance2026-03-21 07:27:43

AST SpaceMobile’s Patent-Protected Direct-to-Cell Play Faces Looming SpaceX IPO Threat
101 finance2026-03-21 07:30:51

Dizal’s ZEGFROVY Nears First-Line Standard Status as Phase 3 Win Unlocks New Market
101 finance2026-03-21 12:03:40

Tesla’s Terafab Gambit: Can It Solve 2nm Chip Hurdles Before Burning Through $40 Billion?
101 finance2026-03-21 13:30:41
CELLPOINT stock price change
On the last trading day, CELLPOINT stock closed at 14.30 INR, with a price change of 2.14% for the day.
Trade stock perpsCELLPOINT stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more